Literature DB >> 22442060

For breast cancer prognosis, immunoglobulin kappa chain surfaces to the top.

Theresa L Whiteside1, Soldano Ferrone.   

Abstract

The stromal immunoglobulin kappa chain (IGKC) has been validated as an immunologic biomarker of prognosis and response to therapy in human breast cancer and other cancers. This validation emphasizes the key role of humoral immunity in control of cancer progression and has major implications for determining prognosis of patients with cancer. ©2012 AACR.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22442060      PMCID： PMC3426232          DOI： 10.1158/1078-0432.CCR-12-0566

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  12 in total

Review 1.  Cancer vaccines inducing antibody production: more pros than cons.

Authors:  Erika Jensen-Jarolim; Josef Singer
Journal:  Expert Rev Vaccines       Date:  2011-09       Impact factor: 5.217

2.  Class distribution of immunoglobulin-containing plasma cells in the stroma of medullary carcinoma of breast.

Authors:  T Ito; S Saga; S Nagayoshi; M Imai; A Aoyama; T Yokoi; M Hoshino
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

3.  Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.

Authors:  Jérôme Galon; Anne Costes; Fatima Sanchez-Cabo; Amos Kirilovsky; Bernhard Mlecnik; Christine Lagorce-Pagès; Marie Tosolini; Matthieu Camus; Anne Berger; Philippe Wind; Franck Zinzindohoué; Patrick Bruneval; Paul-Henri Cugnenc; Zlatko Trajanoski; Wolf-Herman Fridman; Franck Pagès
Journal:  Science       Date:  2006-09-29       Impact factor: 47.728

4.  Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.

Authors:  Bernhard Mlecnik; Marie Tosolini; Amos Kirilovsky; Anne Berger; Gabriela Bindea; Tchao Meatchi; Patrick Bruneval; Zlatko Trajanoski; Wolf-Herman Fridman; Franck Pagès; Jérôme Galon
Journal:  J Clin Oncol       Date:  2011-01-18       Impact factor: 44.544

5.  Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast.

Authors:  Julia A Coronella; Catherine Spier; Matthew Welch; Katrina T Trevor; Alison T Stopeck; Hugo Villar; Evan M Hersh
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

6.  The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells.

Authors:  M H Hansen; H Nielsen; H J Ditzel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

7.  The humoral immune system has a key prognostic impact in node-negative breast cancer.

Authors:  Marcus Schmidt; Daniel Böhm; Christian von Törne; Eric Steiner; Alexander Puhl; Henryk Pilch; Hans-Anton Lehr; Jan G Hengstler; Heinz Kölbl; Mathias Gehrmann
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

8.  Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies.

Authors:  Silvia Benvenuti; Andrea Sartore-Bianchi; Federica Di Nicolantonio; Carlo Zanon; Mauro Moroni; Silvio Veronese; Salvatore Siena; Alberto Bardelli
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

9.  The prognostic significance of B lymphocytes in invasive carcinoma of the breast.

Authors:  S M A Mahmoud; A H S Lee; E C Paish; R D Macmillan; I O Ellis; A R Green
Journal:  Breast Cancer Res Treat       Date:  2011-06-14       Impact factor: 4.872

10.  The immune score as a new possible approach for the classification of cancer.

Authors:  Jérôme Galon; Franck Pagès; Francesco M Marincola; Magdalena Thurin; Giorgio Trinchieri; Bernard A Fox; Thomas F Gajewski; Paolo A Ascierto
Journal:  J Transl Med       Date:  2012-01-03       Impact factor: 5.531
View more
  15 in total

1.  Tumor-Infiltrating Lymphocytes and Their Role in Solid Tumor Progression.

Authors:  Theresa L Whiteside
Journal:  Exp Suppl       Date:  2022

2.  Immune aspects of the breast tumor microenvironment.

Authors:  Akhil Chawla; Gheath Alatrash; Yun Wu; Elizabeth A Mittendorf
Journal:  Breast Cancer Manag       Date:  2013-05-01

3.  Potential biomarkers in the sera of breast cancer patients from bahawalpur, pakistan.

Authors:  Faiz-Ul-Hassan Nasim; Samina Ejaz; Muhammad Ashraf; Abdul Rehman Asif; Michael Oellerich; Gulzar Ahmad; Gulzar Ahmad Malik
Journal:  Biomark Cancer       Date:  2012-12-10

Review 4.  B cell-regulated immune responses in tumor models and cancer patients.

Authors:  Carlo Fremd; Florian Schuetz; Christof Sohn; Philipp Beckhove; Christoph Domschke
Journal:  Oncoimmunology       Date:  2013-07-01       Impact factor: 8.110

5.  Fluoxetine Regulates Ig Kappa Chain C Region Expression Levels in the Serum of Obsessive-Compulsive Disorder Patients: A proteomic Approach.

Authors:  Mona Zamanian Azodi; Mostafa Rezaei Tavirani; Afsaneh Arefi Oskouie; Mostafa Hamdieh; Mohammad Kamran Derakhshan; Alireza Ahmadzadeh; Farid Zayeri; Naser Nejadi; Majid Rezaei Tavirani; Vahid Mansouri; Mohammad Rostami-Nejad; Reza Vafaee
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

6.  Immune responses to cancer: are they potential biomarkers of prognosis?

Authors:  Theresa L Whiteside
Journal:  Front Oncol       Date:  2013-05-17       Impact factor: 6.244

7.  Immunoglobulin kappa chain as an immunologic biomarker of prognosis and chemotherapy response in solid tumors.

Authors:  Marcus Schmidt; Patrick Micke; Mathias Gehrmann; Jan G Hengstler
Journal:  Oncoimmunology       Date:  2012-10-01       Impact factor: 8.110

8.  Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.

Authors:  Julia Beretov; Valerie C Wasinger; Ewan K A Millar; Peter Schwartz; Peter H Graham; Yong Li
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

9.  High Densities of Tumor-Associated Plasma Cells Predict Improved Prognosis in Triple Negative Breast Cancer.

Authors:  Joe Yeong; Jeffrey Chun Tatt Lim; Bernett Lee; Huihua Li; Noel Chia; Clara Chong Hui Ong; Weng Kit Lye; Thomas Choudary Putti; Rebecca Dent; Elaine Lim; Aye Aye Thike; Puay Hoon Tan; Jabed Iqbal
Journal:  Front Immunol       Date:  2018-05-30       Impact factor: 7.561

10.  Proteomics Profiling of Autologous Blood and Semen Exosomes from HIV-infected and Uninfected Individuals Reveals Compositional and Functional Variabilities.

Authors:  Hussein Kaddour; Yuan Lyu; Jennifer L Welch; Victor Paromov; Sammed N Mandape; Shruti S Sakhare; Jui Pandhare; Jack T Stapleton; Siddharth Pratap; Chandravanu Dash; Chioma M Okeoma
Journal:  Mol Cell Proteomics       Date:  2019-11-01       Impact factor: 7.381
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.